Stock Analiz

Capricor Therapeutics, Inc. (CAPR) stock forecast and price target

Price $9.53 · data as of November 13, 2026

12-month price target

Average target$27.25
Upside / downside+185.9%
Analysts6
ConsensusBuy
Low $10.50Average $27.25High $54.00

Gold marker: average target · white marker: today’s price ($9.53)

Analyst ratings

Strong buy 1Buy 4Hold 5Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.45−8.5%$13M
Next fiscal year
ends December 31, 2027
$-1.43+41.6%$66M
Quarter after
ends December 31, 2026
$-0.44+28.6%$11M

Consensus of the analysts covering Capricor Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 7 lowered.

Frequently asked questions

What is the Capricor Therapeutics stock price target?

The average 12-month target from 6 analysts is $27.25, 185.9% above the current price of $9.53 Targets range from $10.50 to $54.00.

Is Capricor Therapeutics a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 4 buy, 5 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Capricor Therapeutics expected to earn?

Analysts expect EPS of $-2.45 for the fiscal year ending December 31, 2026 and $-1.43 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.